Solventum Corporation
SOLVHealthcareNASDAQMedical Instruments & Supplies · Last scanned Sep 8, 2026
Scan Results
Daily timeframeSolventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. Valued at $15.61B, SOLV is a large-cap name in its sector. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems.
Market Cap
$15.61B
Beta
0.69
P/E (TTM)
11.21
P/E (Fwd)
12.69
EPS (TTM)
$8.18
EPS (Fwd)
$7.22
ROE
34.0%
ROA
2.7%
Cash
$403.0M
Total Debt
$5.30B
Free CF
$489.0M
52W Change
25.8%
Annual Financials
Cash vs Debt
Where SOLV stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, SOLV finished 21.16% above its 150-day moving average ($75.85) and 19.00% above its 200-day moving average ($77.23). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is SOLV overbought or oversold?
At the September 3, 2026 close, SOLV's RSI(14) was 75.5, in overbought territory (above 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The company holds $403.0M in cash, though total debt stands at $5.30B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Annual free cash flow of $489.0M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 34.0%, which is exceptionally high for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 2.7% is on the lower side, which is common in asset-heavy industries. Revenue has been relatively flat, moving from $8.13B (2022) to $8.32B (2025).
The relatively low beta of 0.69 suggests SOLV is a less volatile holding compared to the broader index. Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. No single metric tells the full story. Reviewing SOLV's risk profile alongside its fundamentals and technical indicators provides a more complete picture.